Reaction
Total Complement Activity Decreased reporting signals
As of the last recalculation, Total Complement Activity Decreased appears in 59 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 1,872.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 49 | 1,872.1 | 1,873.8 |
| Ravulizumab | 7 | 207.2 | 207.3 |